Wells Fargo & Company »

Cytomx Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $797 515 1.55
2023-09-30 $627 487 1.29
2023-06-30 $822 478 1.72
2022-12-31 $720 450 1.60
2022-09-30 $999 438 2.28
2022-06-30 $999 407 2.46
2022-03-31 $228k 85k 2.68
2021-12-31 $453k 105k 4.33
2021-09-30 $0 91k 0.00
2021-06-30 $336k 53k 6.34
2021-03-31 $1.1M 145k 7.73
2020-12-31 $654k 100k 6.55
2020-09-30 $714k 107k 6.65
2020-06-30 $839k 101k 8.34
2020-03-31 $206k 27k 7.66
2019-12-31 $204k 25k 8.30
2019-09-30 $181k 25k 7.37
2019-06-30 $260k 23k 11.23
2019-03-31 $861k 80k 10.76
2018-12-31 $1.6M 108k 15.09
2018-09-30 $1.8M 95k 18.51
2018-06-30 $2.1M 91k 22.85
2018-03-31 $1.7M 60k 28.52
2017-12-31 $3.0M 142k 21.11
2017-06-30 $638k 41k 15.48
2017-03-31 $387k 22k 17.24
2016-12-31 $161k 15k 10.97
2016-09-30 $122k 7.8k 15.62
2016-06-30 $23k 2.2k 10.42
2016-03-31 $31k 2.4k 12.98
2015-12-31 $47k 2.2k 21.03